PREDICTIVE VALUE OF CIRCULATING ENDOTHELIAL CELL (CEC) LEVELS IN METASTATIC OR LOCALLY ADVANCED NEUROENDOCRINE DIGESTIVE TUMOR PATIENTS TREATED WITH CHEMOTHERAPY AND BEVACIZUMAB

被引：0
|
作者：
Farace, F. F. [1 ]
Lombard-Bohas, C. [2 ]
Mitry, E. [3 ]
Ychou, M. [4 ]
Bengrine-Lefevre, L. [5 ]
Lecomte, T. [6 ]
Joly, K. [7 ]
Ducreux, M. [8 ]
Baudin, E.
机构：
[1] Inst Gustave Roussy, Lab Translat Res, Villejuif, France
[2] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France
[3] Inst Curie, Paris, France
[4] Ctr Val dAurelle, Montpellier, France
[5] Hop St Antoine, F-75571 Paris, France
[6] Hop Trousseau, Tours, France
[7] Roche Biomed Labs, Boulogne Billancourt, France
[8] Inst Cancerol Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [31] Prognostic value of circulating tumor cells with podoplanin expression in locally advanced and metastatic head and neck squamous cell carcinoma
    Tseng, Ching-Ping
    Lin, Hung-Chih
    Hsieh, Chia-Hsun
    Wang, Hung-Ming
    Cheng, Ju-Chien
    CANCER RESEARCH, 2014, 74 (19)
  • [32] Elevated levels of circulating endothelial cells in advanced or metastatic pancreatic carcinoma patients
    Bellone, G.
    Carbone, A.
    Novarino, A.
    Scirelli, T.
    Giacobino, A.
    Milanesi, E.
    Bertetto, O.
    Ciuffreda, L.
    Emanuelli, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI55 - XI55
  • [33] The predictive value of histological tumor regression grading (TRG) for therapeutic evaluation in locally advanced esophageal carcinoma treated with neoadjuvant chemotherapy
    Guo, Kang
    Cai, Ling
    Zhang, Yu
    Zhu, Jian-Fei
    Rong, Tie-Hua
    Lin, Peng
    Hao, Chong-Li
    Wang, Wu-Ping
    Li, Zhe
    Zhang, Lan-Jun
    CHINESE JOURNAL OF CANCER, 2012, 31 (08) : 399 - 408
  • [34] Sequential Circulating Tumor Cell Counts in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: Monitoring the Treatment Response
    Rau, Kun-Ming
    Liu, Chien-Ting
    Hsiao, Yu-Chiao
    Hsiao, Kai-Yin
    Wang, Tzu-Min
    Hung, Wei-Shan
    Su, Yu-Li
    Liu, Wei-Ching
    Wang, Cheng-Hsu
    Hsu, Hsueh-Ling
    Chuang, Po-Heng
    Cheng, Ju-Chien
    Tseng, Ching-Ping
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [35] PROGNOSTIC VALUE OF CD109+CIRCULATING ENDOTHELIAL CELLS IN GLIOBLASTOMA PATIENTS TREATED WITH BEVACIZUMAB
    Cuppini, L.
    Calleri, A.
    Bruzzone, M.
    Prodi, E.
    Anghileri, E.
    Pellegatta, S.
    Mancuso, P.
    Bertolini, F.
    Finocchiaro, G.
    Eoli, M.
    NEURO-ONCOLOGY, 2012, 14 : 14 - 14
  • [36] Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab
    Rossi, G.
    Tagliamento, M.
    Alama, A.
    Coco, S.
    Genova, C.
    Rijavec, E.
    Barletta, G.
    Biello, F.
    Vanni, I.
    Boccardo, S.
    Dal Bello, M. G.
    Alessandra, R.
    Fontana, V.
    Grossi, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S730 - S731
  • [37] The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients
    Zhuo, Minglei
    Chen, Hanxiao
    Zhang, Tianzhuo
    Yang, Xue
    Zhong, Jia
    Wang, Yuyan
    An, Tongtong
    Wu, Meina
    Wang, Ziping
    Huang, Jing
    Zhao, Jun
    CANCER BIOMARKERS, 2018, 22 (03) : 467 - 476
  • [38] The association of toxicities and outcomes with circulating endothelial cells (CEC) in non-small cell lung cancer (NSCLC) patients (pts) treated with bevacizumab (Bev).
    Sadraei, Nooshin Hashemi
    Du, Lingling
    Yadav, Ruchi
    Grane, Ronald
    Jacobs, Barbara
    Hamulak, John
    Ma, Patrick C.
    Pennell, Nathan A.
    Elson, Paul
    Borden, Ernest C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
    Antoine Vasseur
    Luc Cabel
    Olivier Tredan
    Marion Chevrier
    Coraline Dubot
    Véronique Lorgis
    William Jacot
    Anthony Goncalves
    Marc Debled
    Christelle Levy
    Jean-Marc Ferrero
    Christelle Jouannaud
    Elisabeth Luporsi
    Marie-Ange Mouret-Reynier
    Florence Dalenc
    Jerome Lemonnier
    Alexia Savignoni
    Marie-Laure Tanguy
    Francois-Clement Bidard
    Jean-Yves Pierga
    Angiogenesis, 2020, 23 : 193 - 202
  • [40] Prognostic value of CEC count in HER2-negative metastatic breast cancer patients treated with bevacizumab and chemotherapy: a prospective validation study (UCBG COMET)
    Vasseur, Antoine
    Cabel, Luc
    Tredan, Olivier
    Chevrier, Marion
    Dubot, Coraline
    Lorgis, Veronique
    Jacot, William
    Goncalves, Anthony
    Debled, Marc
    Levy, Christelle
    Ferrero, Jean-Marc
    Jouannaud, Christelle
    Luporsi, Elisabeth
    Mouret-Reynier, Marie-Ange
    Dalenc, Florence
    Lemonnier, Jerome
    Savignoni, Alexia
    Tanguy, Marie-Laure
    Bidard, Francois-Clement
    Pierga, Jean-Yves
    ANGIOGENESIS, 2020, 23 (02) : 193 - 202
12345